1421707-06-3

Basic information

• Product Name: [1'-[(E)-cinnamyl]-5-(4-fluorophenyl)sulfanylspiro[indoline-3,4'-piperidine]-1-yl]-(2-methyl-4-pyridyl)methanone
• Synonyms: [1'-[(E)-cinnamyl]-5-(4-fluorophenyl)sulfanylspiro[indoline-3,4'-piperidine]-1-yl]-(2-methyl-4-pyridyl)methanone
• CAS NO: 1421707-06-3
• Molecular Weight: 549.712
• Mol File: 1421707-06-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: [1'-[(E)-cinnamyl]-5-(4-fluorophenyl)sulfanylspiro[indoline-3,4'-piperidine]-1-yl]-(2-methyl-4-pyridyl)methanone(CAS DataBase Reference)
• NIST Chemistry Reference: [1'-[(E)-cinnamyl]-5-(4-fluorophenyl)sulfanylspiro[indoline-3,4'-piperidine]-1-yl]-(2-methyl-4-pyridyl)methanone(1421707-06-3)
• EPA Substance Registry System: [1'-[(E)-cinnamyl]-5-(4-fluorophenyl)sulfanylspiro[indoline-3,4'-piperidine]-1-yl]-(2-methyl-4-pyridyl)methanone(1421707-06-3)

Safety Data

• Hazardous Substances Data: 1421707-06-3(Hazardous Substances Data)

Upstream product

• 24900-69-4 4-(4-fluorophenyl)sulfanylaniline 
• 100-00-5 4-chlorobenzonitrile 
• 371-42-6 4-Fluorothiophenol 
• 2438-85-9 4-fluorophenyl 4′-nitrophenyl sulfide 
• 104-55-2 3-phenyl-propenal 
• 1421708-21-5 benzyl 5-(4-fluorophenyl)sulfanyl-1-(2-methylpyridine-4-carbonyl)spiro[indoline-3,4'-piperidine]-1'-carboxylate 
• 1421708-18-0 benzyl 5-(4-fluorophenyl)sulfanylspiro[indoline-3,4'-piperidine]-1'-carboxylate 

Relevant articles and documents

NOVEL SPIROINDOLINE COMPOUNDS

This invention relates to novel spiroindoline compounds of formula (I) that are generally useful as medicaments, more specifically as medicaments for animals. The medicament can preferably be used for the treatment of helminth infections and the treatment of parasitosis, such as caused by helminth infections. This invention also relates to uses of the compounds to make medicaments and treatments comprising the administration of the compounds to animals in need of the treatments. This invention also relates to the preparation of said compounds. Moreover this invention relates to pharmaceutical compositions and kits comprising the compounds.